🩺 Sphincter of Oddi Manometry Diagnostic Simulator

Patient Selection for Sphincter of Oddi Manometry

Sphincter of Oddi manometry (SOM) is the historical gold-standard test for measuring pressure across the biliary and pancreatic sphincter — but it is an invasive procedure with a meaningful pancreatitis risk, so careful patient selection is the first and most important diagnostic step.

• ~10–20%: Post-cholecystectomy pain, no cause found (candidate population)
• 10–30%: SOM-related pancreatitis risk (notably high vs other ERCP)
• ~85–95%: Type I SOD (structural), respond to EST (high responder rate)
• Low: Type III SOD (functional only) (response, often no true SOD)

What the sphincter of Oddi does

The sphincter of Oddi (SO) is a complex of smooth muscle fibers surrounding the distal common bile duct, main pancreatic duct, and their common channel as they traverse the duodenal wall. It regulates bile and pancreatic exocrine flow into the duodenum, prevents duodeno-biliary reflux, and coordinates with the migrating motor complex.

Sphincter of Oddi dysfunction (SOD) refers to either structural stenosis (fibrosis, scarring — sometimes termed "papillary stenosis") or a functional motility disorder causing intermittent, painful outflow obstruction despite the absence of stones or tumor.

The Milwaukee / Rome IV classification

Historically, biliary SOD was classified (Hogan-Geenen / "Milwaukee" system) as:

• Type I: biliary pain + abnormal liver enzymes + dilated CBD (>12mm) — structural stenosis highly likely, SOM often skipped in favor of empiric sphincterotomy • Type II: biliary pain + only one objective abnormality (either enzymes or duct dilation) — SOM has diagnostic value here • Type III: biliary-type pain alone, no objective abnormality — SOM rarely shows elevated pressure and response to sphincterotomy is poor; the EPISOD trial showed no benefit of sphincterotomy in this group

Rome IV functional GI disorder criteria now discourage manometry and empiric sphincterotomy in Type III-equivalent presentations given the EPISOD trial findings.

The landmark EPISOD randomized trial (2014) found that sphincterotomy was no better than sham procedure for patients with pain alone and no objective findings (old "Type III") — fundamentally changing practice toward reserving invasive testing for patients with objective abnormalities.

Weighing risk versus diagnostic yield

Because SOM carries the highest post-ERCP pancreatitis risk of any ERCP-related procedure (largely from prolonged pancreatic sphincter zone instrumentation and perfusion), it should only be pursued when the result will materially change management — typically in Type II-equivalent patients being considered for endoscopic sphincterotomy, and ideally performed by an experienced high-volume operator with aspirating or solid-state (non-perfusion) catheters and prophylactic pancreatic stenting to mitigate risk.

Triple-Lumen Catheter Placement Across the Sphincter

Accurate manometry depends on correctly positioning a specialized catheter so its recording ports straddle the sphincter zone. Two catheter technologies are used clinically: water-perfused triple-lumen systems and solid-state microtransducer catheters.

• 2 mm: Catheter port spacing (radially offset (triple-lumen))
• ~0.05–0.5: Perfusion rate (mL/min/lumen (low-compliance))
• 4–10 mm: Sphincter zone length (typical high-pressure zone)
• Lower: Solid-state pancreatitis risk reduction (vs perfusion catheters)

Water-perfused triple-lumen catheters

The classic system uses three lumens, each opening at a different point around the catheter circumference (radially spaced 120° apart) and slightly offset longitudinally. Each lumen is perfused with degassed water at a very low, constant rate using a low-compliance pneumohydraulic pump. As each port passes through the high-pressure sphincter zone, resistance to outflow rises, and the pressure transmitted back through the water column is measured by external transducers.

Because fluid must be continuously infused into the pancreatic and biliary ducts, this technique itself contributes some volume load thought to raise post-procedure pancreatitis risk.

Solid-state microtransducer catheters

Newer solid-state (or "Sleeve"/aspirating) catheters incorporate miniature pressure transducers directly at the catheter tip, eliminating the need for continuous perfusion. These reduce injected fluid volume into the pancreatic duct and are associated with lower rates of manometry-induced pancreatitis, though they are more expensive and less widely available than perfusion systems.

Positioning under fluoroscopic and pressure guidance

The catheter is passed through the duodenoscope working channel into the bile duct (or pancreatic duct, tested separately) over a guidewire, then withdrawn slowly toward the duodenal lumen. The transition from duodenal baseline pressure (near zero, referenced to atmospheric) to duct pressure to the high-pressure sphincter zone is tracked in real time, confirming correct catheter position before formal recording begins.

Station Pull-Through Pressure Recording

The core data-acquisition technique in SOM is the "station pull-through": the catheter is withdrawn in small, precise steps, pausing at each station to allow pressures to stabilize and be recorded — mapping the sphincter's pressure profile with millimeter resolution.

• 1–2 mm: Pull-through increment (per station)
• ~30 sec: Recording time per station (to reach steady state)
• Duodenal: Reference baseline (lumen pressure = 0 mmHg)
• 15–30: Typical total exam duration (minutes)

The pull-through protocol

Starting from within the duct (biliary or pancreatic), the catheter is withdrawn in 1–2 mm steps toward the duodenal lumen. At each station, movement stops and pressure is allowed to equilibrate for roughly 30 seconds, generating a stable recording before advancing to the next station. This produces a continuous pressure profile as the recording ports cross duct → sphincter zone → duodenum.

Both the biliary and pancreatic sphincter segments are typically assessed in sequence, since they can behave discordantly (e.g., elevated biliary basal pressure with normal pancreatic pressure, or vice versa).

Distinguishing basal tone from phasic contractions

Two distinct signals are captured simultaneously:

• Basal pressure: the steady-state resting tone of the sphincter, measured relative to duodenal baseline — analogous to resting muscle tone. This is the primary diagnostic parameter. • Phasic contractions: rhythmic, superimposed waves of contraction (3–6 per minute normally) that actively propel bile/pancreatic juice, similar to peristalsis. Their amplitude, frequency, and propagation direction (antegrade, retrograde, or simultaneous) provide additional information about sphincter motor function.

Because the sphincter has independent biliary and pancreatic sub-segments, thorough SOM records both, since dysfunction may be isolated to one segment and management decisions (biliary vs. dual sphincterotomy) depend on which is abnormal.

Artifacts and technical pitfalls

Catheter movement artifact, respiratory variation, duodenal peristaltic contractions transmitted to the catheter, and incomplete stabilization at a station can all distort the tracing. Experienced interpretation requires recognizing and excluding artifactual pressure spikes from genuine sphincter zone measurements — a key reason SOM is best performed and read by high-volume, specialized centers.

Basal and Phasic Wave Analysis

Once the raw pressure tracing is captured, it must be systematically analyzed to extract the quantitative parameters that define normal versus abnormal sphincter function — chiefly the mean basal pressure, but also phasic wave characteristics that add diagnostic nuance.

• <35 mmHg: Normal basal pressure (above duodenal baseline)
• >35–40 mmHg: Abnormal (SOD) threshold (most-used cutoff)
• 3–6/min: Normal phasic frequency (contraction rate)
• ~95–120 mmHg: Normal phasic amplitude (wave peak)

The primary parameter: mean basal pressure

Basal sphincter pressure is calculated as the mean of the stable recordings at the high-pressure zone stations, referenced against duodenal baseline (set to zero). A basal pressure exceeding 35–40 mmHg is the most widely accepted, reproducible criterion for sphincter of Oddi dysfunction, and correlates best with clinical response to sphincterotomy among all manometric parameters studied.

Secondary phasic wave parameters

While less predictive than basal pressure, phasic wave abnormalities are sometimes noted:

• Tachyoddia: contraction frequency >6–8/min, occasionally seen with opioid use or SOD • Retrograde propagation: contractions traveling from duodenum toward the duct rather than the normal antegrade direction, theoretically impeding outflow • Paradoxical response to cholecystokinin (CCK) analogues: in normal physiology CCK relaxes the sphincter; a paradoxical pressure increase has been described in some SOD patients, though this provocative testing is not routinely used given limited reproducibility

Confounders that elevate pressure artificially

Certain medications and physiological states can raise measured sphincter pressure independent of true SOD, and should be controlled for or accounted for during interpretation: opioid analgesics (including those given for procedural sedation) markedly increase sphincter tone; anticholinergics and some sedatives (e.g., glucagon is used to relax smooth muscle and is often given at the start of the study to minimize duodenal motion artifact rather than affect the sphincter itself); and the study is ideally performed with minimal or no opioid administration to avoid false-positive elevation.

Diagnostic Classification and Treatment Decision

The final step integrates the manometric findings with the patient's clinical presentation to arrive at a diagnosis of sphincter of Oddi dysfunction and to determine whether endoscopic sphincterotomy — the definitive treatment — is warranted.

• ~70–90%: EST response, elevated basal pressure (symptom improvement)
• Low: EST response, normal manometry (~modest placebo-level)
• Considered: Dual (biliary+pancreatic) sphincterotomy (if both segments abnormal)
• ~10–15%: Post-SOM pancreatitis (overall) (even with precautions)

Diagnostic synthesis

A diagnosis of manometrically confirmed SOD requires: (1) a clinical presentation consistent with biliary or pancreatic-type pain, (2) exclusion of stones, tumor, and other structural causes on imaging (MRCP, EUS), and (3) an elevated basal sphincter pressure (>35–40 mmHg) on manometry, ideally reproduced on repeat measurement given known variability of the test.

Treatment: endoscopic sphincterotomy

For patients with manometrically confirmed elevated basal pressure and an appropriate clinical picture (historically Type II SOD), endoscopic biliary — and if the pancreatic segment is also abnormal, dual biliary and pancreatic — sphincterotomy is the definitive treatment, durably lowering sphincter resistance and relieving symptoms in the majority of appropriately selected patients.

For patients without objective findings and normal or unclear manometry, sphincterotomy is now discouraged given the EPISOD trial results, and alternative management (pain modulators, smooth muscle relaxants, psychological support for functional pain) is favored.

Because SOM itself carries substantial pancreatitis risk, many high-risk Type II-equivalent patients today are managed with empiric biliary sphincterotomy without manometry, reserving SOM for cases where the diagnosis is genuinely uncertain and will change the treatment plan.

Risk mitigation during and after the procedure

Given the elevated pancreatitis risk of SOM (especially pancreatic sphincter manometry), standard risk-reduction bundles are applied: rectal NSAIDs (indomethacin) periprocedurally, prophylactic pancreatic duct stent placement in high-risk patients, use of aspirating/solid-state catheters where available, minimizing pancreatic duct injection and instrumentation time, and adequate post-procedure observation for early signs of pancreatitis.

SOD classification and manometry findings